(Q45862841)

English

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

author name string

Melero I

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Duarte M

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Ruiz J

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Sangro B

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Galofré J

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Mazzolini G

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Bustos M

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Qian C

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

1779-1784

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301010

0 references

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Activation of human dendritic cells through CD40 cross-linking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Histochemical staining following LacZ gene transfer underestimates transfection efficiency.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

21 January 2018

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-12: a cytokine at the interface of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301010

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516729

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45862841&oldid=2086810571"